TGA
Therapeutic Goods (Permissible Ingredients) Determination (No.3) 2026
Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 – external site which commenced on 16 October 2026. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026 – external site.
This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods (Permissible Ingredients) Determination page.
A complete list of the 10 changed ingredients is below:
Changed ingredients
| Substance name | Change |
|---|---|
| magnesium L-threonate monohydrate | Addition |
| mitoquinol mesilate | Addition |
| gamma glutamylcysteine | Addition |
| styrene/isoprene/styrene block copolymer | Addition |
| hydrocarbons, C6-C20, polymers, hydrogenated | Addition |
| Bacillus coagulans | Change |
| Bacillus subtilis | Change |
| Akkermansia muciniphila | Change |
| Terminalia ferdinandiana | Change |
| 2-methyl-4-propyl-1,3-oxathiane | Change |
/Public Release. View in full here.
